Phase II Dose-ranging Study of Pyronaridine/Artesunate in Adults Patients With Plasmodium Falciparum Malaria
Clinical trial NCT01594931 · COMPLETED
Trial details
- NCT number
- NCT01594931
- Sponsor
- Medicines for Malaria Venture
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2006-03-01
- Enrollment
- 477
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.